ADHD Drug Shortage Set to Ease as Generic Vyvanse Approved

For millions of American patients and parents struggling to fill prescriptions for ADHD medications that are in short supply, help is on the way.

US regulators approved a generic form of Takeda Pharmaceuticals Co.’s Vyvanse, which some patients may be able to take in place of generic Adderall, the drug of choice for many with ADHD. That drug, made by a number of manufacturers, has been in shortage for a year, forcing patients and their families to scour pharmacies for supplies or go without.

The approval will also likely bring financial relief to the more-than one million Americans ...